Eye & ENT Hospital of Fudan University
142
48
50
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.7%
1 terminated/withdrawn out of 142 trials
96.0%
+9.5% vs industry average
12%
17 trials in Phase 3/4
0%
0 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (142)
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
Role: lead
Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma
Role: lead
Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa
Role: lead
SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma
Role: lead
Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study
Role: lead
A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma
Role: lead
Shanghai High Myopia Study
Role: collaborator
Acupuncture Therapy for Sudden Sensorineural Hearing Loss
Role: lead
Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid
Role: collaborator
Fudan Tinnitus Doctor for Tinnitus Management
Role: lead
Electroacupuncture for Mild-to-moderate Dry Eye
Role: collaborator
Trans-round Window Membrane Intracochlear Steroid
Role: lead
Evaluating App-Based Vision Testing (WHOeyes) Combined With the Questionnaire as a Substitute for One-Week Postoperative In-Clinic Follow-Up in Age-Related Cataract Patients: A Multi-center Randomized Controlled Trial
Role: collaborator
Functional IOL Implantation in Patients With Epiretinal Membrane
Role: lead
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
Role: lead
A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma
Role: lead
Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma
Role: lead
Cochlear Implant Recipients: Comprehensive Longitudinal Evaluation
Role: lead
Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal
Role: lead
New Pattern of Retinal Laser Treatment for PDR
Role: lead